Patent: 5,965,125
✉ Email this page to a colleague
Summary for Patent: 5,965,125
Title: | Hybrid matrix implants and explants |
Abstract: | An implantable device having a body of matrix material made up of insoluble collagen fibrils, and disposed therewithin (a) a plurality of vertebrate cells; and (b) a plurality of microspheres each of which consists primarily of one or more of the following materials: collagen, polystyrene, dextran, polyacrylamide, cellulose, calcium alginate, latex, polysulfone, or glass. |
Inventor(s): | Mineau-Hanschke; Rochelle (Waltham, MA) |
Assignee: | Transkaryotic Therapies, Inc. (Cambridge, MA) |
Application Number: | 08/548,002 |
Patent Claims: | see list of patent claims |
Details for Patent 5,965,125
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |